Merck & Co Inc

NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024

MRK Articles

Merck reported better-than-expected third-quarter earnings Monday morning.
Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."
thinkstockOctober 13, 2014: Markets opened lower on Monday, a holiday for all but the equity markets. There was no economic news of note, with reports of a railroad merger and a new CEO getting most...
Short sellers have decided to get out of some of the go-to defensive stocks with high-dividend yields in late September.
thinkstockOctober 8, 2014: Markets opened mixed on Wednesday with virtually no economic data and little other news until the release of the last FOMC meeting minutes. That perked up the markets due...
thinkstockOctober 3, 2014: Markets opened higher on Friday following the report on September non-farm payrolls which showed better-than-expected improvement. The trade deficit was also lower in...
The bull market may be five and a half years old, but stocks have been fighting each week to hit newer highs. These are the best- and worst-performing Dow stocks so far in 2014.
24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.
The bull market may be five and a half years old, but stocks have been fighting each week to hit newer highs.
Here are the four "Gold Standard" stocks from Credit Suisse that offer a combination of a higher yield and more safety than U.S. Treasury debt.
A new research report from UBS focuses on four top companies that are making great strides in treatments for patients -- and generating gigantic revenues.
thinkstockSeptember 12, 2014: Markets opened lower on Friday as the energy sector and utilities opened weaker. The stronger dollar weakens the crude price and raises Treasury rates which hurts...
The short interest data for the August 29 settlement date is out, and we have decided to look at what is happening in the short interest of the go-to high-dividend defensive stocks.
thinkstockSeptember 5, 2014: Markets opened lower on Friday following a disappointing report on employment that investors later took as a signal that the Fed might extend its easy money policy. The...
Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.